Published in J Hepatol on June 02, 2008
An overview of occult hepatitis B virus infection. World J Gastroenterol (2011) 1.32
Molecular characteristics of occult hepatitis B virus from blood donors in southeast China. J Clin Microbiol (2009) 1.14
Diagnostic algorithm for HBV safe transfusion. Blood Transfus (2009) 1.08
Post-transfusion occult hepatitis B (OBI): a global challenge for blood recipients and health authorities. Hepat Mon (2011) 0.97
Occult hepatitis B virus infection among Egyptian blood donors. World J Hepatol (2013) 0.92
Occult hepatitis B virus infection. World J Hepatol (2014) 0.90
Hepatitis B virus (HBV) infection and recombination between HBV genotypes D and E in asymptomatic blood donors from Khartoum, Sudan. J Clin Microbiol (2010) 0.89
Characterization of occult hepatitis B virus infection from blood donors in China. J Clin Microbiol (2011) 0.89
Factors in enhancing blood safety by nucleic acid technology testing for human immunodeficiency virus, hepatitis C virus and hepatitis B virus. Asian J Transfus Sci (2014) 0.87
Reducing the risk of hepatitis B virus transfusion-transmitted infection. J Blood Med (2011) 0.82
Ultradeep Sequencing for Detection of Quasispecies Variants in the Major Hydrophilic Region of Hepatitis B Virus in Indonesian Patients. J Clin Microbiol (2015) 0.81
Surface antigen-negative hepatitis B virus infection in Dutch blood donors. Eur J Clin Microbiol Infect Dis (2013) 0.79
Molecular virology in transfusion medicine laboratory. Blood Transfus (2012) 0.79
Characterization of Novel Hepatitis B Virus PreS/S-Gene Mutations in a Patient with Occult Hepatitis B Virus Infection. PLoS One (2016) 0.78
Occult Hepatitis B Virus Infection in Nigerian Blood Donors and Hepatitis B Virus Transmission Risks. PLoS One (2015) 0.78
Specific amino acid substitutions in the S protein prevent its excretion in vitro and may contribute to occult hepatitis B virus infection. J Virol (2013) 0.77
An Improved NAT Assay with Enhanced Sensitivity for HBV for Donor Blood Screening. J Lab Physicians (2012) 0.77
Mutations associated with occult hepatitis B in HIV-positive South Africans. J Med Virol (2014) 0.76
T-Cell Response to Hepatitis B Core Antigen: Identification of Prior Exposure to and Confirmatory Testing for Screening for Anti-HBc. J Biomark (2013) 0.75
Characterisation and follow-up study of occult hepatitis B virus infection in anti-HBc-positive qualified blood donors in southern China. Blood Transfus (2016) 0.75
Occult Hepatitis B virus infection in previously screened, blood donors in Ile-Ife, Nigeria: implications for blood transfusion and stem cell transplantation. Virol J (2016) 0.75
Investigation of a Novel Hepatitis B Virus Surface Antigen (HBsAg) Escape Mutant Affecting Immunogenicity. PLoS One (2017) 0.75
Prevalence and characterization of occult hepatitis B infection among blood donors in central Saudi Arabia. Saudi Med J (2016) 0.75
Hepatitis B surface gene variants isolated from blood donors with overt and occult HBV infection in north eastern Egypt. Virol J (2015) 0.75
Characteristics of escape mutations from occult hepatitis B virus infected patients with hematological malignancies in South Egypt. World J Hepatol (2017) 0.75
Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol (2008) 3.50
Predonation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource-poor settings. Transfusion (2005) 3.08
Hyperglycemia after SAH: predictors, associated complications, and impact on outcome. Stroke (2005) 2.36
Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus. Transfusion (2008) 2.27
18F-FDG PET/CT identifies patients at risk for future vascular events in an otherwise asymptomatic cohort with neoplastic disease. J Nucl Med (2009) 2.19
Development of a real-time PCR assay for Trypanosoma cruzi detection in blood samples. Acta Trop (2007) 2.12
The global spread of hepatitis C virus 1a and 1b: a phylodynamic and phylogeographic analysis. PLoS Med (2009) 2.06
Prognostic significance of continuous EEG monitoring in patients with poor-grade subarachnoid hemorrhage. Neurocrit Care (2006) 1.89
Linkage disequilibrium inflates type I error rates in multipoint linkage analysis when parental genotypes are missing. Hum Hered (2005) 1.86
Virus-mediated transduction of murine retina with adeno-associated virus: effects of viral capsid and genome size. J Virol (2002) 1.77
Transfusion-transmitted hepatitis B virus infection. J Hepatol (2009) 1.70
Nucleic acid testing to detect HBV infection in blood donors. N Engl J Med (2011) 1.69
High-frequency oscillatory ventilation reduces lung inflammation: a large-animal 24-h model of respiratory distress. Intensive Care Med (2007) 1.68
Development of an unbiased method for the estimation of liver steatosis. Clin Transplant (2004) 1.53
The effect of a novel recombination between the homeobox gene NKX2-5 and the TRD locus in T-cell acute lymphoblastic leukemia on activation of the NKX2-5 gene. Haematologica (2006) 1.52
1,25-Dihydroxyvitamin D fluctuations in cardiac surgery are related to age and clinical outcome*. Crit Care Med (2012) 1.52
Frequent recovery and broad genotype 2 diversity characterize hepatitis C virus infection in Ghana, West Africa. J Virol (2003) 1.50
Italian blood donors with anti-HBc and occult hepatitis B virus infection. Haematologica (2007) 1.47
Novel genes for airway wall thickness identified with combined genome-wide association and expression analyses. Am J Respir Crit Care Med (2015) 1.44
Infectivity of blood products from donors with occult hepatitis B virus infection. Transfusion (2013) 1.43
Presence of phosphodiesterase type 5 in the spinal cord and its involvement in bladder outflow obstruction related bladder overactivity. J Urol (2013) 1.43
Identification and characterization of persistent human erythrovirus infection in blood donor samples. J Virol (2004) 1.43
Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa. Transfusion (2009) 1.41
Persistence of HTLV-I in blood components after leukocyte depletion. Blood (2002) 1.39
Persistent B19 infection in immunocompetent individuals: implications for transfusion safety. Blood (2005) 1.39
Blood donor screening for parvovirus B19 in Germany and Austria. Transfusion (2007) 1.35
Multiplex real-time quantitative RT-PCR assay for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus type 1. J Virol Methods (2004) 1.33
Structural-mechanical characterization of nanoparticle exosomes in human saliva, using correlative AFM, FESEM, and force spectroscopy. ACS Nano (2010) 1.32
Anti-HBs positive occult hepatitis B virus carrier blood infectious in two transfusion recipients. J Hepatol (2008) 1.30
Identification and genetic diversity of two human parvovirus B19 genotype 3 subtypes. J Gen Virol (2007) 1.28
Local adeno-associated virus-mediated interleukin 10 gene transfer has disease-modifying effects in a murine model of Sjögren's syndrome. Hum Gene Ther (2003) 1.28
Bacterial contamination of platelet concentrates: results of a prospective multicenter study comparing pooled whole blood-derived platelets and apheresis platelets. Transfusion (2007) 1.27
Maternofetal transmission of hepatitis B virus genotype E in Ghana, west Africa. J Gen Virol (2007) 1.23
Epidermal growth factor receptor is a co-receptor for adeno-associated virus serotype 6. Nat Med (2010) 1.22
Dating the origin and dispersal of hepatitis B virus infection in humans and primates. Hepatology (2013) 1.19
A shortened adeno-associated virus expression cassette for CFTR gene transfer to cystic fibrosis airway epithelia. Proc Natl Acad Sci U S A (2005) 1.17
Different chromosomal breakpoints impact the level of LMO2 expression in T-ALL. Blood (2007) 1.15
BMP4 and CNTF are neuroprotective and suppress damage-induced proliferation of Müller glia in the retina. Mol Cell Neurosci (2004) 1.15
Sensitivity of HCV RNA and HIV RNA blood screening assays. Transfusion (2002) 1.15
Cellular immune response to hepatitis C virus (HCV) in nonviremic blood donors with indeterminate anti-HCV reactivity. Transfusion (2009) 1.13
Exposure to high stress in the intensive care unit may have negative effects on health-related quality-of-life outcomes after cardiac surgery. Crit Care Med (2003) 1.13
Adeno-associated virus type 5: transduction efficiency and cell-type specificity in the primate retina. Hum Gene Ther (2003) 1.12
Genetic variants altering dopamine D2 receptor expression or function modulate the risk of opiate addiction and the dosage requirements of methadone substitution. Pharmacogenet Genomics (2009) 1.10
Hepatitis B virus transmission by blood transfusion during 4 years of individual-donation nucleic acid testing in South Africa: estimated and observed window period risk. Transfusion (2011) 1.10
Adeno-associated virus serotype 2-mediated gene transfer to the parotid glands of nonhuman primates. Hum Gene Ther (2007) 1.10
Remote ischemic preconditioning decreases adhesion and selectively modifies functional responses of human neutrophils. J Surg Res (2010) 1.08
Blood screening for influenza. Emerg Infect Dis (2007) 1.07
Activation of miR-17-92 by NK-like homeodomain proteins suppresses apoptosis via reduction of E2F1 in T-cell acute lymphoblastic leukemia. Leuk Lymphoma (2009) 1.07
Transfusion in sub-Saharan Africa: does a Western model fit? J Clin Pathol (2007) 1.06
Sufficient blood, safe blood: can we have both? BMC Med (2012) 1.05
Modifying the product pattern of Clostridium acetobutylicum: physiological effects of disrupting the acetate and acetone formation pathways. Appl Microbiol Biotechnol (2012) 1.05
Ototoxicity of artemether/lumefantrine in the treatment of falciparum malaria: a randomized trial. Malar J (2008) 1.05
Characterization of HBV DNA+/HBsAg- blood donors in Poland identified by triplex NAT. Hepatology (2006) 1.04
High-resolution whole-body magnetic resonance image tumor staging with the use of parallel imaging versus dual-modality positron emission tomography-computed tomography: experience on a 32-channel system. Invest Radiol (2005) 1.04
Hepatitis C virus and hepatitis B virus bind to heparin: purification of largely IgG-free virions from infected plasma by heparin chromatography. J Gen Virol (2005) 1.03
Population physiology: leveraging electronic health record data to understand human endocrine dynamics. PLoS One (2012) 1.03
Simultaneous visual detection of multiple viral amplicons by dipstick assay. J Clin Microbiol (2005) 1.02
Hepatitis B virus genotype G monoinfection and its transmission by blood components. Hepatology (2006) 1.01
Molecular characterization of occult hepatitis B virus in genotype E-infected subjects. J Gen Virol (2008) 1.01
Consensus summary statement of the International Multidisciplinary Consensus Conference on Multimodality Monitoring in Neurocritical Care : a statement for healthcare professionals from the Neurocritical Care Society and the European Society of Intensive Care Medicine. Intensive Care Med (2014) 1.01
Correlation of in vitro platelet quality measurements with in vivo platelet viability in human subjects. Vox Sang (2006) 1.00
Efficacy of hepatitis B virus (HBV) DNA screening and characterization of acute and occult HBV infections among blood donors from Madrid, Spain. Transfusion (2009) 1.00
Protective effect of HLA-B57 on HCV genotype 2 infection in a West African population. J Med Virol (2007) 1.00
Full genome characterization of hepatitis B virus strains from blood donors in Iran. J Med Virol (2011) 1.00
Characterization of periplasmic protein BP26 epitopes of Brucella melitensis reacting with murine monoclonal and sheep antibodies. PLoS One (2012) 1.00
Identification of adeno-associated virus contamination in cell and virus stocks by PCR. Biotechniques (2004) 0.99
Head-to-head comparison of two transcription-mediated amplification assay versions for detection of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus Type 1 in blood donors. Transfusion (2013) 0.99
Occult hepatitis B infection in blood donors from South East Asia: molecular characterisation and potential mechanisms of occurrence. Gut (2012) 0.99
The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) study: outcomes from the acute and continuation phases. Biol Psychiatry (2007) 0.99
Characterization of occult hepatitis B virus strains in South African blood donors. Hepatology (2009) 0.99
Increasing threat of brucellosis to low-risk persons in urban settings, China. Emerg Infect Dis (2014) 0.98
Epstein-Barr virus-associated lymphoproliferative disorders. Postepy Hig Med Dosw (Online) (2013) 0.98
A novel hepatitis B virus subgenotype, D7, in Tunisian blood donors. J Gen Virol (2009) 0.98
Stress doses of hydrocortisone reduce chronic stress symptoms and improve health-related quality of life in high-risk patients after cardiac surgery: a randomized study. J Thorac Cardiovasc Surg (2006) 0.98
Simultaneous chemoradiotherapy compared with radiotherapy alone after induction chemotherapy in inoperable stage IIIA or IIIB non-small-cell lung cancer: study CTRT99/97 by the Bronchial Carcinoma Therapy Group. J Clin Oncol (2006) 0.98
External financial aid to blood transfusion services in sub-Saharan Africa: a need for reflection. PLoS Med (2012) 0.98
Genome-wide transcriptome analysis in murine neural retina using high-throughput RNA sequencing. Genomics (2011) 0.97
A cluster of human immunodeficiency virus Type 1 recombinant form escaping detection by commercial genomic amplification assays. Transfusion (2010) 0.97
DiGeorge syndrome critical region 8 (DGCR8) protein-mediated microRNA biogenesis is essential for vascular smooth muscle cell development in mice. J Biol Chem (2012) 0.97
Association of low ejection fraction with impaired verbal memory in older patients with heart failure. Arch Neurol (2011) 0.97
Multiplex real-time PCR for the detection and quantification of latent and persistent viral genomes in cellular or plasma blood fractions. J Virol Methods (2008) 0.97
Evaluation of a new hepatitis B virus surface antigen rapid test with improved sensitivity. J Clin Microbiol (2008) 0.96
Intellectual disability is associated with increased runs of homozygosity in simplex autism. Am J Hum Genet (2013) 0.96
Intracranial multimodal monitoring for acute brain injury: a single institution review of current practices. Neurocrit Care (2010) 0.96
Transmissibility of hepatitis B virus (HBV) infection through blood transfusion from blood donors with occult HBV infection. Clin Infect Dis (2011) 0.95
Angiotensin type 2 receptor-mediated apoptosis of human prostate cancer cells. Mol Cancer Ther (2009) 0.95
Diagnosis of chronic obstructive pulmonary disease in lung cancer screening Computed Tomography scans: independent contribution of emphysema, air trapping and bronchial wall thickening. Respir Res (2013) 0.95
Pilot studies for development of an HIV subtype panel for surveillance of global diversity. AIDS Res Hum Retroviruses (2012) 0.95
Pathogen-free, plasma-poor platelet lysate and expansion of human mesenchymal stem cells. J Transl Med (2014) 0.94
A probable case of hepatitis B virus transfusion transmission revealed after a 13-month-long window period. Transfusion (2008) 0.94